NAD+ hydrolase Sarm1 is a key driver of synapse degeneration and memory loss in Alzheimer's disease
Fan FaniD, Prince Joshi, Xiaojie LiuiD, Sandeep Kumar KotturuiD, Michael Abayomi AbiolaiD, Q. Liu, Xuelin LouiD
Abstract
Synapse degeneration is a hallmark of neurodegenerative diseases1-3, including Parkinsons and Alzheimers disease (AD). Synapse loss has been known for decades as the strongest correlate with cognition and disease progression in AD patients4-8, but the molecular mechanisms that drive synapse degeneration remain elusive. Here, we identify Sarm1, a new class of NAD+ hydrolase required for Wallerian degeneration of periphery nerves after injuries9-12, as the key mediator of synaptic degeneration in AD brains. Sarm1 knockout largely reversed synapse loss, amyloid-{beta} (A{beta}) burden, and cognitive decline in 5XFAD mice. We found that Sarm1 is enriched in synaptic terminals and becomes activated in synaptic dystrophies adjacent to A{beta} plaques, leading to synapse degeneration and subsequent neuroinflammation. Sarm1 deletion in the AD mice prevented synaptic dystrophies and rescued short-term and long-term synaptic plasticity. Further, Sarm1 deletion protected synapses from C1q tagging and phagocytosis, and C1q-MERTK signaling in complement cascades 7,13-15 was significantly reduced. The reduced synapse degeneration, in turn, broke the feed-forward loop of "glia activation-neuroinflammation-A{beta} deposition". These data suggest that Sarm1 plays a key role in driving synapse degeneration in AD before C1q-tagging and phagocytic clearance, and targeting Sarm1 may offer a novel intervention to attenuate synapse degeneration and memory loss in AD. HighlightO_LISarm1 is enriched at presynaptic dystrophies and correlated with A{beta}. C_LIO_LIGenetic deletion of Sarm1 prevents synapse degeneration in AD. C_LIO_LISarm1 depletion is sufficient to reverse synaptic dysfunction and memory loss. C_LIO_LISarm1 depletion reduces A{beta} burden and neuroinflammation C_LIO_LIC1q--MERTK axis acts downstream of synaptic Sarm1 activation. C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=121 SRC="FIGDIR/small/695860v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@bd6b12org.highwire.dtl.DTLVardef@1c089e5org.highwire.dtl.DTLVardef@19d35fborg.highwire.dtl.DTLVardef@431364_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synaptic degeneration in neuronal circuits hinders memory recall, memory rescue, and learning
Kwan Tung Li, Daoyun Ji, Changsong Zhou·bioRxiv·Aug 22, 2022
- Synapsin-caveolin-1 mitigates cognitive deficits and neurodegeneration in Alzheimer's disease mice
Shanshan Wang, Joseph S. Leem, … Brian Patrick Head·bioRxiv·Jul 24, 2020
- SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment
Guadalupe Pereyra, María Inés Mateo, … Paola Bovolenta·Cell ReportsPeer-reviewed·Apr 1, 2025
- Sertad1 is elevated and plays a necessary role in synaptic loss, neuron death and cognitive impairment in a model of Alzheimer's disease
Naqiya Ambareen, Kusumika Gharami, Subhas Chandra Biswas·bioRxiv·Aug 6, 2024
- SorCS1 promotes synaptic and cognitive resilience despite amyloid pathology in Alzheimer's disease model mice
Nayoung Yi, Alfred Kihoon Lee, … Hideto Takahashi·bioRxiv·Aug 27, 2026
- Differential Effects of Neutral Sphingomyelinase and Serine Palmitoyltransferase Inhibitors on Alzheimer's-Like Neuropathology.
Melina Bellotto, Nicolás González Pérez, … Juan Beauquis·bioRxiv·Sep 11, 2026